E

Eton Pharmaceuticals
D

ETON

18.730
USD
-0.21
(-1.11%)
Market Open
Volume
7,657
EPS
0
Div Yield
-
P/E
-104
Market Cap
502,024,255
Related Instruments
ABT
ABT
-0.390
(-0.29%)
133.260 USD
AMGN
AMGN
-1.30
(-0.45%)
287.04 USD
AZN
AZN
-1.040
(-1.43%)
71.770 USD
BMY
BMY
0.305
(0.63%)
48.570 USD
GSK
GSK
0.285
(0.69%)
41.320 USD
JNJ
JNJ
-0.270
(-0.17%)
154.740 USD
LLY
LLY
2.89
(0.39%)
741.45 USD
MRK
MRK
-1.250
(-1.63%)
75.570 USD
NVS
NVS
0.430
(0.37%)
116.170 USD
PFE
PFE
-0.120
(-0.51%)
23.370 USD
SNY
SNY
-0.280
(-0.57%)
49.050 USD
More
News

Title: Eton Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.